---
category: news
title: "Moderna Announces FDA Nod For Phase 2 Coronavirus Vaccine Study, Hints At Approval In 2021"
excerpt: "Moderna Inc (NASDAQ: MRNA) reported Thursday ahead of the market open with a first-quarter loss that came in line with expectations and also issued an update on its"
publishedDateTime: 2020-05-07T13:11:00Z
webUrl: "https://www.benzinga.com/general/biotech/20/05/15977346/moderna-announces-fda-nod-for-phase-2-coronavirus-vaccine-study-hints-at-approval-in-2021"
ampWebUrl: "https://amp.benzinga.com/amp/content/15977346"
cdnAmpWebUrl: "https://amp-benzinga-com.cdn.ampproject.org/c/s/amp.benzinga.com/amp/content/15977346"
type: article
quality: 65
heat: 65
published: false

provider:
  name: Benzinga.com
  domain: benzinga.com

topics:
  - Treatment
  - Coronavirus

images:
  - url: "https://www.benzinga.com/files/images/story/2012/syringe-3902915_1920_2.jpg"
    width: 1920
    height: 1280
    title: "Moderna Announces FDA Nod For Phase 2 Coronavirus Vaccine Study, Hints At Approval In 2021"

secured: "D8KCe0TbEtfOV1E+VHa7J6SUlCx/lN0EqcmZbdE1C+cXtyC1gwhJ1k9tGLP3hFrkusvfzlW4Tsko5fcBHv17kR57LwgznZcl3BJqvKfnlPHuvroiwdwjZbZ1WS1t4LQ7RRgb3OE3g2S4kPIK4SMknmro7zjzEemARyvRzD1f2VNKJKRq11Bu04srfWJLemMa+iazQJnWezFSOTmE8l0kKiat+1l+QWRBp0eRy4tftLgl5HZ67kwisDEfkfRePa6XxNf/G0BbCL0fkF+WYLWsAmbtUWHLYNjWeU7ExbbHRti7U91soumWq3TKNwn9gae8;ARnG4eEFnDZcQdUeiWXFDw=="
---

